We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 03, 2021

Trastuzumab in HER2+ Breast Cancer: A Protocol for Systematic Review and Meta-Analysis

Medicine (Baltimore)


Additional Info

Medicine (Baltimore)
Clinical Therapeutic Effects of Trastuzumab in HER2-Positive Breast Cancer Patients: A Protocol for Systematic Review and Meta-Analysis
Medicine (Baltimore) 2021 Apr 30;100(17)e25685, C Tong, C Wang, K Yang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading